GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                            
                            
                            
                                 Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: MRL-248 is a selective, small molecule antagonist of RORγt, an isoform of RORγ (RAR related orphan receptor C), with antiinflammatory potential [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References | 
| Rheumatoid arthritis | 
                                                                    
                                                                        Disease Ontology: 
                                                                        DOID:7148 OMIM: 180300  | 
                                                                Experimental compound with predicted application in RA. | |
| Inflammatory bowel disease | 
                                                                    
                                                                        Disease Ontology: 
                                                                        DOID:0050589 OMIM: 266600  | 
                                                                Experimental compound with predicted application in inflammatory bowel disease. | |
| Psoriatic arthritis | 
                                                                    
                                                                        Disease Ontology: 
                                                                        DOID:9008 | 
                                                                Experimental compound with predicted application in PsA. | |
| Ankylosing spondylitis | 
                                                                    
                                                                        Disease Ontology: 
                                                                        DOID:7147 | 
                                                                Experimental compound with predicted application in ankylosing spondylitis. | |